Komori
OLBA DVx HEALTHCARE (2689) · RiskMaterialised

Simultaneous revisions to medical and long-term care fees in fiscal 2018 and healthcare cost optimization

First written in FY2017. 5 of 8 entries say "Restated". Latest entry: FY2026-H1.

8entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY2024-Q22017: 12018: 120182019: 120192020: 020202021: 020212022: 120222023: 220232024: 120242025: 020252026: 1
Same theme, other companies

OLBA DVx HEALTHCARE moved to the "Worse" side of this theme in 2026, 1 year after the typical company in this theme (2025).

The whole theme swung hardest in 2026: 7 of 16 companies on the "Worse" side.

6 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 19 companies compared. The sentences above are computed from all 19.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1MaterialisedAnnual report

    「Although there was positive news, including a substantial increase in the basic component of medical fee revisions in April 2026 and the enactment of a supplementary budget, medical institutions continued to face labor shortages and soaring prices during the interim period, and their cautious stance toward capital investment remained unchanged.」

    The revision of medical fees was implemented, and an increase in the basic fee component and the approval of a supplementary budget were described as changes in the business environment. Meanwhile, labor shortages at medical institutions, rising prices, and a cautious stance toward capital investment continue.
  2. FY2024-Q2RestatedAnnual report

    「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」

    No significant changes are reported regarding external environmental risks related to revisions of medical and long-term care fees and healthcare cost optimization.
  3. FY2024-Q1RestatedAnnual report

    「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    No significant changes are reported regarding external environmental risks related to revisions of medical and long-term care fees and healthcare cost optimization.
  4. FY2023-Q2RestatedAnnual report

    「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」

    No significant changes are reported regarding external environmental risks related to revisions of medical and long-term care fees and healthcare cost optimization.
  5. FY2023-Q1RestatedAnnual report

    「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    No significant changes are reported regarding external environmental risks related to revisions of medical and long-term care fees and healthcare cost optimization.
  6. FY2019RestatedAnnual report

    「The simultaneous revision of medical and long-term care fees implemented in April 2018 was a major revision incorporating various measures.」

    The fiscal 2018 simultaneous revision of medical and long-term care fees continues to be addressed in the full-year management analysis as an external factor affecting the business environment.
  7. FY2018MaterialisedAnnual report

    「The simultaneous revision of medical and long-term care fees in April this year was a major revision incorporating various measures aimed at establishing a sustainable public health insurance system and healthcare delivery system for the coming year 2025.」

    The fiscal 2018 simultaneous revision of medical and long-term care fees, which had been identified as a forecast and concern in the previous fiscal year, was implemented, and its effects on the healthcare delivery system and business environment are described.
  8. FY2017First statedAnnual report

    「Meanwhile, medical and long-term care fees will be revised simultaneously in fiscal 2018. The basic policy toward 2025, when all members of the so-called baby-boom generation will be aged 75 or older, is expected to remain largely unchanged from the previous revision. The key points are expected to be the functional differentiation of and stronger coordination among healthcare providers to enhance the sustainability of the healthcare system, together with greater efficiency and optimization of healthcare costs.」

    The simultaneous fiscal 2018 revision of medical and long-term care fees, along with the functional differentiation of and stronger coordination among healthcare providers and greater efficiency and optimization of healthcare costs toward 2025, is identified as an environmental factor affecting the industry.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
OLBA DVx HEALTHCARE's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Simultaneous revisions to medical and long-term care fees in fiscal 2018 and healthcare cost optimization | OLBA DVx HEALTHCARE,Inc. (2689) | Komori